Cytomegalovirus skin disease in a kidney transplant patient. Cervera-Hernandez MEnrique, Ikemura K, McCort ME. 2021. Cytomegalovirus skin disease in a kidney transplant patient.. BMJ Case Rep. 14(7) Read more about Cytomegalovirus skin disease in a kidney transplant patient. Google Scholar
Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality. Billett HH, Reyes-Gil M, Szymanski J, Ikemura K, Stahl LR, Lo Y, Rahman S, Gonzalez-Lugo JD, Kushnir M, Barouqa M et al.. 2020. Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality.. Thromb Haemost. 120(12):1691-1699. Read more about Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality. Google Scholar
Correlation of Coagulation Parameters With Clinical Outcomes During the Coronavirus-19 Surge in New York: Observational Cohort. Gil MReyes, Gonzalez-Lugo JD, Rahman S, Barouqa M, Szymanski J, Ikemura K, Lo Y, Billett HH. 2021. Correlation of Coagulation Parameters With Clinical Outcomes During the Coronavirus-19 Surge in New York: Observational Cohort.. Front Physiol. 12:618929. Read more about Correlation of Coagulation Parameters With Clinical Outcomes During the Coronavirus-19 Surge in New York: Observational Cohort. Google Scholar
Using Automated Machine Learning to Predict the Mortality of Patients With COVID-19: Prediction Model Development Study. Ikemura K, Bellin E, Yagi Y, Billett H, Saada M, Simone K, Stahl L, Szymanski J, Goldstein DY, Gil MReyes. 2021. Using Automated Machine Learning to Predict the Mortality of Patients With COVID-19: Prediction Model Development Study.. J Med Internet Res. 23(2):e23458. Read more about Using Automated Machine Learning to Predict the Mortality of Patients With COVID-19: Prediction Model Development Study. Google Scholar
Factors associated with myocardial SARS-CoV-2 infection, myocarditis, and cardiac inflammation in patients with COVID-19. Bearse M, Hung YP, Krauson AJ, Bonanno L, Boyraz B, Harris CK, T Helland L, Hilburn CF, Hutchison B, Jobbagy S et al.. 2021. Factors associated with myocardial SARS-CoV-2 infection, myocarditis, and cardiac inflammation in patients with COVID-19.. Mod Pathol. 34(7):1345-1357. Read more about Factors associated with myocardial SARS-CoV-2 infection, myocarditis, and cardiac inflammation in patients with COVID-19. Google Scholar
How SARS-CoV-2 Transformed the Clinical Laboratory: Challenges and Lessons Learned. Tsai JM, Tolan NV, Petrides AK, Kanjilal S, Brigl M, Lindeman NI, Der Li Y-, Tanasijevic MJ, Basu SS, Melanson SEF. 2021. How SARS-CoV-2 Transformed the Clinical Laboratory: Challenges and Lessons Learned.. J Appl Lab Med. 6(5):1338-1354. Read more about How SARS-CoV-2 Transformed the Clinical Laboratory: Challenges and Lessons Learned. Google Scholar
The skin as a critical window in unveiling the pathophysiologic principles of COVID-19. Magro C, Nuovo G, J Mulvey J, Laurence J, Harp J, A Crowson N. 2021. The skin as a critical window in unveiling the pathophysiologic principles of COVID-19.. Clin Dermatol. 39(6):934-965. Read more about The skin as a critical window in unveiling the pathophysiologic principles of COVID-19. Google Scholar
The histologic and molecular correlates of COVID-19 vaccine-induced changes in the skin. Magro C, A Crowson N, Franks L, Schaffer PRouhani, Whelan P, Nuovo G. 2021. The histologic and molecular correlates of COVID-19 vaccine-induced changes in the skin.. Clin Dermatol. 39(6):966-984. Read more about The histologic and molecular correlates of COVID-19 vaccine-induced changes in the skin. Google Scholar
Care disruptions among patients with lung cancer: A COVID-19 and cancer outcomes study. Bhalla S, Bakouny Z, Schmidt AL, Labaki C, Steinharter JA, Tremblay DA, Awad MM, Kessler AJ, Haddad RI, Evans M et al.. 2021. Care disruptions among patients with lung cancer: A COVID-19 and cancer outcomes study.. Lung Cancer. 160:78-83. Read more about Care disruptions among patients with lung cancer: A COVID-19 and cancer outcomes study. Google Scholar
COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION). Wang X, Gkrouzman E, Andrade DCastro Oli, Andreoli L, Barbhaiya M, H Belmont M, Branch DWare, de Jesús GR, Efthymiou M, Ríos-Garcés R et al.. 2021. COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION).. Lupus. 30(14):2276-2285. Read more about COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION). Google Scholar
